ArticleJournal of cell science2017
Suppression of intestinal tumorigenesis in
Article in Journal of cell science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 4 citations in OpenAlex.
- Stress granules in colorectal cancer: Current knowledge and potential therapeutic applications.World journal of gastroenterology · 2020Review
- Identification of a novel splice variant of the human musashi-1 gene.Oncology letters · 2018Article
- Ap4 is rate limiting for intestinal tumor formation by controlling the homeostasis of intestinal stem cells.Nature communications · 2018Article
Corrections and comments
- Retraction · 2017-10-23Concerns/Issues about Data · Concerns/Issues about Image · Duplication of/in Image · Investigation by Company/Institution · Investigation by Journal/Publisher · Objections by Third Party · Upgrade/Update of Prior Notice(s) ·
- Expression of concern · 2017-09-21Concerns/Issues about Data · Investigation by Company/Institution · Investigation by Journal/Publisher ·
- Expression of concern
- Retracted
Authors and funding
7 authors at 1 institution in 1 country.
Funding
Abstract
Therapeutic strategies based on a specific oncogenic target are better justified when elimination of that particular oncogene reduces tumorigenesis in a model organism. One such oncogene, Musashi-1 (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.